Use of extracorporeal membrane oxygenation in adults

Heart Lung and Circulation

Volumn 23, Issue 1, 2014, Pages 10-23

  Lafçi, Gökhan ^a   Budak, Ali Baran ^b   Yener, Ali Ümit ^c   Cicek, Omer Faruk ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

Author keywords

Cardiac surgery; Cardiopulmonary insufficiency; Extracorporeal membrane oxygenation; Resuscitation; Ventricular assist devices

Indexed keywords

ADULT; ANTICOAGULANT THERAPY; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BLEEDING; CANNULA; CENTRIFUGAL PUMP; DETERIORATION; EXTRACORPOREAL OXYGENATION; HEALTH CARE PRACTICE; HEART EXCHANGER; HEART FAILURE; HEART OUTPUT; HOSPITAL MANAGEMENT; HUMAN; HYPERBILIRUBINEMIA; INFECTION; INTENSIVE CARE UNIT; KIDNEY FAILURE; LIFE SUPPORT EQUIPMENT; LIMB ISCHEMIA; LONG TERM CARE; MEDICAL DEVICE COMPLICATION; MICROCLIMATE; MULTIPLE ORGAN FAILURE; OXYGENATOR; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; ROLLER PUMP; TUBE; VENO ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION; VENO VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION;

CARDIAC SURGERY; CARDIOPULMONARY INSUFFICIENCY; EXTRACORPOREAL MEMBRANE OXYGENATION; RESUSCITATION; VENTRICULAR ASSIST DEVICES;

ADULT; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEART FAILURE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; LUNG DISEASES; MALE;

EID: 84891836812     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2013.08.009     Document Type: Review

References (108)

1. Daily P.O., Johnston G.G., Simmons C.J., Moser K.M. Surgical management of chronic pulmonary embolism: surgical treatment and late results. J Thorac Cardiovasc Surg 1980, 79(April (4)):523-531.
2. Koutouzis M., Kolsrud O., Albertsson P., Matejka G., Grip L., Kjellman U. Percutaneous coronary intervention facilitated by extracorporeal membrane oxygenation support in a patient with cardiogenic shock. Hellenic J Cardiol 2010, 51(May-June (3)):271-274.
3. Nose Y. Manual on artificial organs: volume II the oxygenator 1973, The C.V. Mosby Company, St. Louis, MO.
4. Bartlett R.H., Isherwood J., Moss R.A., Olszewski W.L., Polet H., Drinker P.A. A toroidal flow membrane oxygenator: four day partial bypass in dogs. Surg Forum 1969, 20:152-153.
5. Peek G.J., Killer H.M., Reeves R., Sosnowski A.W., Firmin R.K. Early experience with a polymethyl pentene oxygenator for adult extracorporeal life support. ASAIO J 2002, 48:480-482.
6. Khoshbin E., Roberts N., Harvey C., Machin D., Killer H., Peek G.J., et al. Poly-methyl pentene oxygenators have improved gas exchange capability and reduced transfusion requirements in adult extracorporeal membrane oxygenation. ASAIO J 2005, 51:281-287.
7. Thiara A.P., Hoel T.N., Kristiansen F., Karlsen H.M., Fiane A.E., Svennevig J.L. Evaluation of oxygenators and centrifugal pumps for long-term pediatric extracorporeal membrane oxygenation. Perfusion 2007, 22:323-326.
8. Moen O., Fosse E., Brockmeier V., Andersson C., Mollnes T.E., Høgåsen K., et al. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems. Ann Thorac Surg 1995, 60:1317-1323.
9. Fosse E., Moen O., Johnson E., Semb G., Brockmeier V., Mollnes T.E., et al. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1994, 58:472-477.
10. Bennett M., Horton S., Thuys C., Augustin S., Rosenberg M., Brizard C. Pump-induced haemolysis: a comparison of short-term ventricular assist devices. Perfusion 2004, 19:107-111.
11. Lawson D.S., Ing R., Cheifetz I.M., Walczak R., Craig D., Schulman S., et al. Hemolytic characteristics of three commercially available centrifugal blood pumps. Pediatr Crit Care Med 2005, 6:573-577.
12. Hill J.D., O'Brien T.G., Murray J.J., Dontigny L., Bramson M.L., Osborn J.J., et al. Prolonged extracorporeal oxygenation acute posttraumatic respiratory failure (shock-lung syndrome), use of the Bramson membrane lung. N Engl J Med 1972, 286:629-634.
13. Zapol W.M., Snider M.T., Hill J.D., Fallat R.J., Bartlett R.H., Edmunds L.H., et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979, 242(November (20)):2193-2196.
14. Gattinoni L., Kolobow T., Damia G., Agostoni A., Pesenti A. Extracorporeal carbon dioxide removal (ECCO2R): a new form of respiratory assistance. Int J Artif Organs 1979 Jul, 2(4):183-185.
15. Kolobow T., Solca M., Gattinoni L., Pesenti A. Adult respiratory distress syndrome (ARDS): why did ECMO fail?. Int J Artif Organs 1981 Mar, 4(2):58-59.
16. 2. Lancet 1980 Aug 9, 2(8189):292-294.
17. 2 removal in severe acute respiratory failure. JAMA 1986, 256(August (7)):881-886.
18. Morris A.H., Wallace C.J., Menlove R.L., Clemmer T.P., Orme J.F., Weaver L.K., et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994 Feb, 149(2 Pt 1):295-305. [erratum in Am J Respir Crit Care Med 1994;149(3 Pt. 1):838].
19. UK Collaborative ECMO Trail Group: UK collaborative randomized trial of neonatal extracorporeal membrane oxygenation. Lancet 1996, 348:75-82.
20. Peek G.J., Mugford M., Tiruvoipati R., Wilson A., Allen E., Thalanany M.M., et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009 Oct 17, 374(9698):1351-1363.
21. Skinner S.C., Hirschl R.B., Bartlett R.H. Extracorporeal life support. Semin Pediatr Surg 2006 Nov, 15(4):242-250.
22. Sidebotham D., McGeorge A., McGuinness S., Edwards M., Willcox T., Beca J. Extracorporeal membrane oxygenation for treating severe cardiac and respiratory failure in adults: part 2-technical considerations. J Cardiothorac Vasc Anesth 2010 Feb, 24(1):164-172.
23. Pettignano R., Fortenberry J.D., Heard M.L., Labuz M.D., Kesser K.C., Tanner A.J., et al. Primary use of the venovenous approach for extracorporeal membrane oxygenation in pediatric acute respiratory failure. Pediatr Crit Care Med 2003 Jul, 4(3):291-298.
24. Betit P. Extracorporeal membrane oxygenation: quo vadis?. Respir Care 2009 Jul, 54(7):948-957.
25. Rich P.B., Awad S.S., Crotti S., Hirschl R.B., Bartlett R.H., Schreiner R.J. A prospective comparison of atrio-femoral and femoro-atrial flow in adult venovenous extracorporeal life support. J Thorac Cardiovasc Surg 1998 Oct, 116(4):628-632.
26. Mielck F., Quintel M. Extracorporeal membrane oxygenation. Curr Opin Crit Care 2005 Feb, 11(1):87-93.
27. Moen O., Fosse E., Bråten J., Andersson C., Høgåsen K., Mollnes T.E., et al. Differences in blood activation related to roller/centrifugal pumps and heparin-coated/uncoated surfaces in a cardiopulmonary bypass model circuit. Perfusion 1996 Mar, 11(2):113-123.
28. Baufreton C., Intrator L., Jansen P.G., te Velthuis H., Le Besnerais P., Vonk A., et al. Inflammatory response to cardiopulmonary bypass using roller or centrifugal pumps. Ann Thorac Surg 1999 Apr, 67(4):972-977.
29. Leschinsky B.M., Itkin G.P., Zimin N.K. Centrifugal blood pumps - a brief analysis: development of new designs. Perfusion 1991, 6(2):115-121.
30. Uretzky G., Landsburg G., Cohn D. Analysis of microembolic particles originating in extracorporeal circuits. Perfusion 1987, 2-9.
31. Wright G. Mechanical simulation of cardiac function by means of pulsatile blood pumps. J Cardiothorac Vasc Anesth 1997 May, 11(3):299-309.
32. Chevalier J.Y., Couprie C., Larroquet M., Renolleau S., Durandy Y., Costil J. Venovenous single lumen cannula extracorporeal lung support in neonates: a five year experience. ASAIO J 1993, 39(July-September (3)):M654-M658.
33. Skogby M., Mellgren K., Adrian K., Friberg L.G., Chevalier J.Y., Mellgren G. Induced cell trauma during in vitro perfusion: a comparison between two different perfusion systems. Artif Organs 1998, 22(December (12)):1045-1051.
34. Montoya J.P., Merz S.I., Bartlett R.H. Significant safety advantages gained with an improved pressure-regulated blood pump. J Extra Corpor Technol 1996, 28(June (2)):71-78.
35. Christiansen S., Göbel C., Buhre W., Reul H., Autschbach R. Successful use of a miniaturized bypass system with the DeltaStream extracorporeal rotary blood pump. J Thorac Cardiovasc Surg 2003, 125(January (1)):43-44.
36. Dembinski R., Kopp R., Henzler D., Hochhausen N., Oslender N., Max M., et al. Extracorporeal gas exchange with the DeltaStream rotary blood pump in experimental lung injury. Artif Organs 2003, 27(June (6)):530-536.
37. Blauth C.I., Smith P.L., Arnold J.V., Jagoe J.R., Wootton R., Taylor K.M. Influence of oxygenator type on the prevalence and extent of microembolic retinal ischemia during cardiopulmonary bypass, assessment by digital image analysis. J Thorac Cardiovasc Surg 1990 Jan, 99(1):61-69.
38. Pearson D.T. Gas exchange: bubble and membrane oxygenators. Semin Thorac Cardiovasc Surg 1990, 2(October (4)):313-319.
39. Haworth W.S. The development of the modern oxygenator. Ann Thorac Surg 2003, 76(December (6)):S2216-S2219.
40. Wiesenack C., Wiesner G., Keyl C., Gruber M., Philipp A., Ritzka M., et al. In vivo uptake and elimination of isoflurane by different membrane oxygenators during cardiopulmonary bypass. Anesthesiology 2002, 97(July (1)):133-138.
41. Motomura T., Maeda T., Kawahito S., Matsui T., Ichikawa S., Ishitoya H., et al. Development of silicone rubber hollow fiber membrane oxygenator for ECMO. Artif Organs 2003, 27(November (11)):1050-1053.
42. Palatianos G.M., Foroulis C.N., Vassili M.I., Astras G., Triantafillou K., Papadakis E., et al. A prospective, double-blind study on the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit. Ann Thorac Surg 2003, 76(July (1)):129-135.
43. Edmunds L.H., Stenach N. The blood-surface interface. Cardiopulmonary bypass: principles and practice 2000, 149. Williams & Wilkins, Media, PA. 2nd ed. G.P. Gravlee, R.F. Davis, M. Kurusz, Utley (Eds.).
44. Koster A., Sänger S., Hansen R., Sodian R., Mertzlufft F., Harke C., et al. Prevalence and persistence of heparin/platelet factor 4 antibodies in patients with heparin coated and noncoated ventricular assist devices. ASAIO J 2000, 46(May-June (3)):319-322.
45. Cruz D., Karlsberg R., Takano Y., Vora D., Tobis J. Subacute stent thrombosis associated with a heparin-coated stent and heparin-induced thrombocytopenia. Catheter Cardiovasc Interv 2003, 58(January (1)):80-83.
46. Plötz F.B., van Oeveren W., Bartlett R.H., Wildevuur C.R. Blood activation during neonatal extracorporeal life support. J Thorac Cardiovasc Surg 1993, 105(May (5)):823-832.
47. Moen O., Høgåsen K., Fosse E., Dregelid E., Brockmeier V., Venge P., et al. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1997, 63(January (1)):105-111.
48. Videm V., Mollnes T.E., Fosse E., Mohr B., Bergh K., Hagve T.A., et al. Heparin-coated cardiopulmonary bypass equipment, I. Biocompatibility markers and development of complications in a high-risk population. J Thorac Cardiovasc Surg 1999, 117(April (4)):794-802.
49. Ranucci M., Mazzucco A., Pessotto R., Grillone G., Casati V., Porreca L., et al. Heparin-coated circuits for high-risk patients: a multicenter, prospective, randomized trial. Ann Thorac Surg 1999, 67(April (4)):994-1000.
50. Geissler H.J., Allen S.J., Mehlhorn U., Davis K.L., de Vivie E.R., Kurusz M., et al. Cooling gradients and formation of gaseous microemboli with cardiopulmonary bypass: an echocardiographic study. Ann Thorac Surg 1997, 64(July (1)):100-104.
51. Oliver W.C. Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth 2009, 13(September (3)):154-175.
52. Despotis G.J., Joist J.H., Hogue C.W., Alsoufiev A., Joiner-Maier D., Santoro S.A., et al. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT. Thromb Haemost 1996, 76(December (6)):902-908.
53. Baird C.W., Zurakowski D., Robinson B., Gandhi S., Burdis-Koch L., Tamblyn J., et al. Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival. Ann Thorac Surg 2007, 83(March (3)):912-919.
54. Martindale S.J., Shayevitz J.R., D'Errico C. The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery. J Cardiothorac Vasc Anesth 1996, 10(June (4)):458-463.
55. Guzzetta N.A., Bajaj T., Fazlollah T., Szlam F., Wilson E., Kaiser A., et al. A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass. Anesth Analg 2008, 106(February (2)):419-425.
56. Codispoti M., Mankad P.S. Management of anticoagulation and its reversal during paediatric cardiopulmonary bypass: a review of current UK practice. Perfusion 2000, 15(June (3)):191-201.
57. Lawson D.S., Walczak R., Lawson A.F., Shearer I.R., Ing R., Schulman S., et al. North American neonatal extracorporeal membrane oxygenation (ECMO) devices: 2002 survey results. J Extra Corpor Technol 2004, 36(March (1)):16-21.
58. Despotis G.J., Summerfield A.L., Joist J.H., Goodnough L.T., Santoro S.A., Spitznagel E., et al. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. J Thorac Cardiovasc Surg 1994, 108(December (6)):1076-1082.
59. Nuttall G.A., Oliver W.C., Santrach P.J., Bryant S., Dearani J.A., Schaff H.V., et al. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001, 94(May (5)):773-781.
60. Agati S., Ciccarello G., Salvo D., Turla G., Undar A., Mignosa C. Use of a novel anticoagulation strategy during ECMO in a pediatric population: single-center experience. ASAIO J 2006, 52(September-October (5)):513-516.
61. De Waele J.J., Van Cauwenberghe S., Hoste E., Benoit D., Colardyn F. The use of the activated clotting time for monitoring heparin therapy in critically ill patients. Intensive Care Med 2003, 29(February (2)):325-328. [Epub 2003 Jan 16].
62. Hirsh J., Raschke R., Warkentin T.E., Dalen J.E., Deykin D., Poller L. Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1995, 108(October (4 Suppl.)):258S-275S.
63. Muntean W. Coagulation and anticoagulation in extracorporeal membrane oxygenation. Artif Organs 1999, 23(November (11)):979-983.
64. Koster A., Weng Y., Böttcher W., Gromann T., Kuppe H., Hetzer R. Successful use of bivalirudin as anticoagulant for ECMO in a patient with acute HIT. Ann Thorac Surg 2007, 83(May (5)):1865-1867.
65. Marasco S.F., Lukas G., McDonald M., McMillan J., Ihle B. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. Heart Lung Circ 2008, 17(Suppl. 4):S41-S47.
66. Spina R., Forrest A.P., Adams M.R., Wilson M.K., Ng M.K., Vallely M.P. Veno-arterial extracorporeal membrane oxygenation for high-risk cardiac catheterisation procedures. Heart Lung Circ 2010, 19(December (12)):736-741.
67. Stroud M.H., Okhuysen-Cawley R., Jaquiss R., Berlinski A., Fiser R.T. Successful use of extracorporeal membrane oxygenation in severe necrotizing pneumonia caused by Staphylococcus aureus. Pediatr Crit Care Med 2007 May, 8(May (3)):282-287.
68. Doll N., Kiaii B., Borger M., Bucerius J., Krämer K., Schmitt D.V., et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg 2004, 77(January (1)):151-157.
69. Beiderlinden M., Eikermann M., Boes T., Breitfeld C., Peters J. Treatment of severe acute respiratory distress syndrome: role of extracorporeal gas exchange. Intensive Care Med 2006, 32(October (10)):1627-1631.
70. Smedira N.G., Moazami N., Golding C.M., McCarthy P.M., Apperson-Hansen C., Blackstone E.H., et al. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg 2001, 122(July (1)):92-102.
71. Schuerer D.J., Kolovos N.S., Boyd K.V., Coopersmith C.M. Extracorporeal membrane oxygenation: current clinical practice, coding, and reimbursement. Chest 2008, 134(July (1)):179-184.
72. Extracorporeal Life Support Registry Report (International Summary) 2008, 30. Extracorporeal Life Support Organization, Ann Arbor, MI.
73. Haile D.T., Schears G.J. Optimal time for initiating extracorporeal membrane oxygenation. Semin Cardiothorac Vasc Anesth 2009, 13(September (3)):146-153.
74. Bakhtiary F., Keller H., Dogan S., Dzemali O., Oezaslan F., Meininger D., et al. Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. J Thorac Cardiovasc Surg 2008, 135(February (2)):382-388.
75. Ko W.J., Lin C.Y., Chen R.J., Wang S.S., Lin F.Y., Chen Y.S. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg 2002, 73(February (2)):538-545.
76. Muehrcke D.D., McCarthy P.M., Stewart R.W., Foster R.C., Ogella D.A., Borsh J.A., et al. Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. Ann Thorac Surg 1996, 61(February (2)):684-691.
77. Fiser S.M., Tribble C.G., Kaza A.K., Long S.M., Zacour R.K., Kern J.A., et al. When to discontinue extracorporeal membrane oxygenation for postcardiotomy support. Ann Thorac Surg 2001, 71:210-214.
78. Delgado D.H., Rao V., Ross H.J., Verma S., Smedira N.G. Mechanical circulatory assistance: state of art. Circulation 2002, 106:2046-2050.
79. Chen J.S., Ko W.J., Yu H.Y., Lai L.P., Huang S.C., Chi N.H., et al. Analysis of the outcome for patients experiencing myocardial infarction and cardiopulmonary resuscitation refractory to conventional therapies necessitating extracorporeal life support rescue. Crit Care Med 2006, 34(April (4)):950-957.
80. Rastan A.J., Dege A., Mohr M., Doll N., Falk V., Walther T., et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 2010, 139(February (2)):302-311.
81. Combes A., Leprince P., Luyt C.E., Bonnet N., Trouillet J.L., Léger P., et al. Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 2008, 36(May (5)):1404-1411.
82. Hei F., Lou S., Li J., Yu K., Liu J., Feng Z., et al. Five-year results of 121 consecutive patients treated with extracorporeal membrane oxygenation at Fu Wai Hospital. Artif Organs 2011, 35(June (6)):572-578.
83. Berman M., Tsui S., Vuylsteke A., Snell A., Colah S., Latimer R., et al. Successful extracorporeal membrane oxygenation support after pulmonary thromboendarterectomy. Ann Thorac Surg 2008, 86(October (4)):1261-1267.
84. Magovern G.J., Simpson K.A. Extracorporeal membrane oxygenation for adult cardiac support: the Allegheny experience. Ann Thorac Surg 1999, 68(August (2)):655-661.
85. Wang J., Han J., Jia Y., Zeng W., Shi J., Hou X., et al. Early and intermediate results of rescue extracorporeal membrane oxygenation in adult cardiogenic shock. Ann Thorac Surg 2009, 88(December (6)):1897-1903.
86. Extracorporeal Life Support Organisation. 2009 ECLS Registry Report (International Summary) 2009, Extracorporeal Life Support Organisation, Ann Arbor, MI.
87. Sidebotham D., McGeorge A., McGuinness S., Edwards M., Willcox T., Beca J. Extracorporeal membrane oxygenation for treating severe cardiac and respiratory disease in adults: Part 1 - overview of extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth 2009, 23(December (6)):886-892.
88. Suzuki T. Additional lung-protective perfusion techniques during cardiopulmonary bypass. Ann Thorac Cardiovasc Surg 2010, 16(June (3)):150-155.
89. Hemmila M.R., Rowe S.A., Boules T.N., Miskulin J., McGillicuddy J.W., Schuerer D.J., et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg 2004, 240(October (4)):595-605.
90. Kasirajan V., Smedira N.G., McCarthy J.F., Casselman F., Boparai N., McCarthy P.M. Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 1999, 15(April (4)):508-514.
91. Burket J.S., Bartlett R.H., Vander Hyde K., Chenoweth C.E. Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation. Clin Infect Dis 1999, 28(April (4)):828-833.
92. Robinson T.M., Kickler T.S., Walker L.K., Ness P., Bell W. Effect of extracorporeal membrane oxygenation on platelets in newborns. Crit Care Med 1993, 21(July (7)):1029-1034.
93. Stallion A., Cofer B.R., Rafferty J.A., Ziegler M.M., Ryckman F.C. The significant relationship between platelet count and haemorrhagic complications on ECMO. Perfusion 1994, 9(4):265-269.
94. Rastan A.J., Lachmann N., Walther T., Doll N., Gradistanac T., Gommert J.F., et al. Autopsy findings in patients on postcardiotomy extracorporeal membrane oxygenation (ECMO). Int J Artif Organs 2006, 29:1121-1131.
95. Kanji H.D., Schulze C.J., Oreopoulos A., Lehr E.J., Wang W., MacArthur R.M. Peripheral versus central cannulation for extracorporeal membrane oxygenation: a comparison of limb ischemia and transfusion requirements. Thorac Cardiovasc Surg 2010, 58:459-462.
96. Thelin S., Bagge L., Hultman J., Borowiec J., Nilsson L., Thorelius J. Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig. Eur J Cardiothorac Surg 1991, 5(9):486-491.
97. Videm V., Svennevig J.L., Fosse E., Semb G., Osterud A., Mollnes T.E. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg 1992, 103(April (4)):806-813.
98. Borowiec J., Thelin S., Bagge L., Nilsson L., Venge P., Hansson H.E. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study. J Thorac Cardiovasc Surg 1992, 104(September (3)):642-647.
99. Glauber M., Szefner J., Senni M., Gamba A., Mamprin F., Fiocchi R., et al. Reduction of haemorrhagic complications during mechanically assisted circulation with the use of a multi-system anticoagulation protocol. Int J Artif Organs 1995, 18(October (10)):649-655.
100. Downard C.D., Betit P., Chang R.W., Garza J.J., Arnold J.H., Wilson J.M. Impact of AMICAR on hemorrhagic complications of ECMO: a ten-year review. J Pediatr Surg 2003, 38(August (8)):1212-1216.
101. Brunet F., Mira J.P., Belghith M., Lanore J.J., Schlumberger S., Toulon P., et al. Effects of aprotinin on hemorrhagic complications in ARDS patients during prolonged extracorporeal CO2 removal. Intensive Care Med 1992, 18(6):364-367.
102. van der Staak F.H., de Haan A.F., Geven W.B., Festen C. Surgical repair of congenital diaphragmatic hernia during extracorporeal membrane oxygenation: hemorrhagic complications and the effect of tranexamic acid. J Pediatr Surg 1997, 32(April (4)):594-599.
103. Wittenstein B., Ng C., Ravn H., Goldman A. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery. Pediatr Crit Care Med 2005, 6(July (4)):473-476.
104. Bui J.D., Despotis G.D., Trulock E.P., Patterson G.A., Goodnough L.T. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg 2002, 124(October (4)):852-854.
105. Conrad S.A., Rycus P.T., Dalton H. Extracorporeal life support registry report 2004. ASAIO J 2005, 51(January-February (1)):4-10.
106. O'Neill J.M., Schutze G.E., Heulitt M.J., Simpson P.M., Taylor B.J. Nosocomial infections during extracorporeal membrane oxygenation. Intensive Care Med 2001, 27(August (8)):1247-1253.
107. Camboni D., Akay B., Sassalos P., Toomasian J.M., Haft J.W., Bartlett R.H., et al. Use of venovenous extracorporeal membrane oxygenation and an atrial septostomy for pulmonary and right ventricular failure. Ann Thorac Surg 2011, 91(January (1)):144-149.
108. Mols G., Loop T., Geiger K., Farthmann E., Benzing A. Extracorporeal membrane oxygenation: a ten-year experience. Am J Surg 2000, 180(August (2)):144-154.